Once a niche pharmaceutical product used quietly in the background of autoimmune and malaria treatments, hydroxychloroquine has been thrust into the spotlight in recent years. From heated pandemic debates to renewed scientific interest, this decades-old drug is now part of a billion-dollar conversation. But what is really driving its resurgence—and is the world prepared for its next...

Just a few years ago, hydroxychloroquine was a name that very few outside the medical world could pronounce, let alone define. But after gaining intense global attention during the pandemic, this decades-old drug has remained firmly in the headlines—and the Hydroxychloroquine Drug Market is proving it's no passing trend. Originally developed to treat malaria, hydroxychloroquine has long...

Can an old anti-malarial drug be the center of a billion-dollar healthcare conversation? It already is. Hydroxychloroquine—once an under-the-radar treatment—has become a hot topic across the globe. But the hype is no longer just about pandemic headlines. The real story now is how its role in autoimmune treatment and chronic illness is triggering rapid growth in the...